Veeva R&D and Quality Summit
We’re hosting Veeva R&D and Quality Summit as an online experience on October 13-14 to connect the industry while prioritizing the safety of our community. Join to see the latest innovations and best practices through live and on-demand sessions. Summit will also feature interactive ways to connect with your peers and Veeva team members.
The preliminary agenda is now available, and we’re excited to announce Amy Abernethy, principal deputy commissioner from the FDA, as the keynote speaker. Amy will share the latest on how the FDA is supporting speeding drug development through technology innovation.
Summit is complimentary for Veeva customers and other drug development professionals in the biopharmaceutical industry.
Key topics included:
- Transforming end-to-end clinical trial processes with a unified clinical operations suite.
- Enhancing collaboration and data sharing between sponsors, CROs, and investigator sites.
- Improving trial efficiency, visibility, and quality.
- Enabling active TMF management and oversight.
- Scaling Vault CDMS globally for any therapeutic area.
- Configuring Vault CDMS to handle your most complex protocol designs.
- Enabling sponsors and CROs to build their own studies.
- Delivering complete and concurrent data with CDB.
- Driving regulatory transformation with greater collaboration.
- Improving efficiency through continuous publishing.
- Streamlining health authority questions, commitments, and correspondence.
- Aligning headquarters and affiliates to optimize regulatory processes.
- Setting up quality systems for success from the start.
- Transforming quality management for 2020 and beyond.
- Unifying and connecting quality to improve collaboration and efficiency.
- Streamlining adverse event collection, evaluation, and reporting.
- Enabling collaboration with real-time oversight.
- Ensuring quality, compliance, and completeness of safety information.
- Staying current on regulatory changes.